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Abstract 
Objective: To compare the effects of neuromuscular exercise (NEXA) and quadriceps 
strengthening (QS) on the knee adduction moment (an indicator of medio-lateral distribution 
of knee load), pain and physical function in people with medial knee joint osteoarthritis (OA) 
and varus malalignment.  
Methods: 100 people with medial knee pain, mostly moderate to severe radiographic medial 
knee OA, and varus malalignment were randomly allocated to one of two 12-week exercise 
programs. Each program involved 14 individually supervised exercise sessions with a 
physiotherapist plus a home exercise component. Primary outcomes were peak external knee 
adduction moment (3D gait analysis), pain (visual analogue scale), and self-reported physical 
function (Western Ontario and McMaster Universities Osteoarthritis Index).  
Results: 82 participants (38 (76%) NEXA, 44 (88%) QS) completed the trial.  There was no 
significant between-group difference in the change in the peak knee adduction moment 
(mean difference (95% CI) 0.134 (-0.069 to 0.337) Nm/(BW.HT)%), pain (2.4 (-6.0 to 10.8) 
mm) or physical function (-0.8 (-4.0 to 2.4) units). Neither group showed a change in knee 
moments following exercise, whereas both groups showed similar significant reductions in 
pain and physical dysfunction.  
Conclusions: Although comparable improvements in clinical outcomes were found for both 
neuromuscular and quadriceps strengthening exercise in people with moderate varus 
malalignment and mostly moderate to severe medial knee OA, these forms of exercise did not 
affect the knee adduction moment, a key predictor of structural disease progression. 
Australia and New Zealand Clinical Trials Registry (#ACTRN12610000660088) 
Key words: neuromuscular exercise, strengthening, knee adduction moment, osteoarthritis 
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Background 
 
Knee osteoarthritis (OA), predominantly affecting the medial tibiofemoral compartment, is a 
common chronic condition leading to pain, loss of function and reduced quality-of-life. 
People with medial knee OA and varus malalignment have greater functional (1) and 
structural (2) decline than those with more neutrally aligned knees. Interventions that not 
only reduce symptoms but also slow disease progression are particularly needed for this 
subgroup of people with knee OA. 
 
The poorer prognosis for such patients is likely facilitated by greater compressive load on the 
diseased compartment (3). Three dimensional gait analysis is typically used to infer 
compressive joint loads. The most widely studied parameter in knee OA is the external knee 
adduction moment (KAM) which reflects medio-lateral joint load distribution. The KAM is 
higher in people with varus malalignment than in those without (4-6) and higher KAM 
indices are associated with increased risk of OA structural progression (7, 8). The KAM is 
therefore a relevant target for treatments to slow disease progression.  
 
Quadriceps strengthening is effective at improving pain and physical function in people with 
knee OA (9, 10). However, quadriceps strengthening may be ineffective at reducing pain in 
those with varus malalignment (11) and it does not seem to reduce the KAM (11, 12). This 
may be because quadriceps strengthening aims to increase muscle force production, rather 
than more directly targeting biomechanical contributors to medial compartment load (such as 
knee adduction moment lever arm length) which may require more specific focus on using 
muscles to control limb and overall body position.  
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Neuromuscular exercise is typically performed in functional weight-bearing positions and 
emphasises quality of movement and alignment of the trunk and lower limb (13). Studies 
show that neuromuscular exercise can improve pain and function in people with knee OA 
(13-15) but that its addition to a strengthening program does not confer additional benefits 
(16, 17). As some features of neuromuscular exercise could affect knee joint load (via limb 
and trunk alignment) this intervention may be beneficial for people with varus malalignment. 
There are no direct comparisons of neuromuscular and strengthening exercise, only 
preliminary findings from two uncontrolled studies supporting the potential efficacy of 
neuromuscular exercise for reducing the KAM (14,18), and no studies of neuromuscular 
training for this specific knee OA subgroup.  
 
This randomised controlled trial aimed to compare the effects of a 12-week neuromuscular 
exercise program with those of quadriceps strengthening in people with medial knee OA and 
varus malalignment. The primary hypotheses were that: (H1) peak KAM during walking 
would be reduced by neuromuscular exercise but not by quadriceps strengthening, leading to 
a significant difference between groups; and (H2) neuromuscular exercise would improve 
self-reported physical function and pain to a greater extent than quadriceps strengthening. 
 
Methods 
Participants 
100 community volunteers aged ≥ 50 years with medial knee OA were recruited from July 
2010 to June 2012 via advertisements. The Institutional ethics committee approved the study 
and all participants provided written informed consent. 
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People were eligible if they reported average knee pain over the past week ≥ 25 on a 100 mm 
visual analogue scale, had pain/tenderness predominantly over the medial knee region, and 
had radiographic medial tibiofemoral joint OA. Specific inclusion criteria from a weight-
bearing, postero-anterior radiograph were (i) Kellgren-Lawrence grade ≥ 2 (19); (ii) 
anatomical axis angle of < 181° for females or < 183° for males, indicating varus alignment 
based on mechanical axis values using gender-specific regression equations from Krauss et al 
(20) (21); (iii) medial tibiofemoral joint narrowing grade > lateral tibiofemoral joint 
narrowing grade (22); and (iv) medial compartment osteophyte grade  lateral compartment 
osteophyte grade (22). Major exclusion criteria included: (i) knee surgery or intra-articular 
corticosteroid injection within six months; (ii) current or past (within four weeks) oral 
corticosteroid use; (iii) systemic arthritic conditions; (iv) prior hip or knee joint replacement 
or tibial osteotomy surgery; (v) other non-pharmacological treatment within past six months; 
(vii) body mass index above 36 kg/m2.  
 
Procedures 
This was a randomised, assessor-blinded, controlled trial.  A detailed protocol has been 
published (23). Potential participants underwent telephone screening, then radiographic 
examination. Following baseline assessment, participants were randomised in permuted 
blocks of 6 or 8, stratified by physiotherapist, to one of two 12-week exercise groups; 
neuromuscular exercise (NEXA) or quadriceps strengthening (QS). The randomisation 
schedule was prepared by the study biostatistician using a computer generated random 
numbers table. Allocations were sealed in opaque consecutively numbered envelopes by a 
person not involved with the trial and these were kept in a central locked location. The 
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envelopes were opened in sequence by an independent administrator who then revealed the 
group allocation to the relevant physiotherapist by email before the participant presented for 
their first appointment.  
 
Interventions 
Nine physiotherapists in private practices delivered both interventions. They had an average 
of 12 (range 2-30) years of clinical musculoskeletal experience. Three (30%) had 
postgraduate masters level qualifications. They attended a three-hour training session and 
were provided with a treatment manual.  
 
The exercise programs have been described in detail elsewhere (23). For both programs, only 
the study leg was specifically exercised. Participants visited their physiotherapist 14 times 
during the 12-weeks: twice in the first and second weeks, and weekly thereafter. Each visit 
lasted 30-40 minutes. Participants were asked to perform home exercises four times per week 
in addition to the supervised physiotherapy sessions.  
 
Neuromuscular exercises  
Participants in the NEXA group performed six exercises aiming to improve position of the 
trunk and lower limb joints relative to one another while dynamically and functionally 
strengthening the lower limb (Table 1, Figure 1, Appendix). During all exercises, the level of 
effort was to be self-rated as at least 5 out of 10 on a modified Borg Rating of Perceived 
Exertion (RPE) CR-10 scale (24). Progression, determined by the physiotherapist, was 
provided by varying the repetitions, direction, and velocity of the movements by increasing 
the load and/or changing the support surface.  
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Quadriceps strengthening  
Participants in the QS group completed five non-weight-bearing exercises based on those 
used in our previous clinical trial (11) (Table 1). The dosage was 2-3 sets of 10 repetitions 
with the starting weight matched to the participant’s 10-repetition maximum weight if 
possible or a weight needed to achieve a self rating of 5-8 out of 10 on the modified Borg 
RPE CR-10 scale (24). Progression was achieved by increasing the number of sets, the 
duration of the hold phase of the exercise, and the ankle weight or elastic band resistance as 
guided by the physiotherapist.  
 
Outcome measures  
Measurements were performed at baseline and follow-up by the same blinded assessor.  
 
Gait analysis 
Participants underwent 3-dimensional gait analysis during walking at their self-selected 
usual/comfortable speed. Movement was recorded using a 12-camera motion analysis system 
(Vicon MX, Oxford, UK) and force plates (AMTI, MA, USA) as participants walked 
barefoot along a 10m walkway. Speed was determined using two photoelectric beams. Five 
successful trials (complete foot strike from one foot on one force plate) were obtained. The 
motion of 37 reflective markers (sample rate 120Hz) and the ground reaction force (sample 
rate 1200Hz) were used to calculate the external KAM via inverse dynamics using the 
University of Western Australia model, programmed in Vicon Body Builder (25).  Test–
retest reliability (coefficient of multiple determination, r2) of knee adduction/abduction 
moment curves has been reported as at least 0.75 (25). The primary variable was the overall 
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peak KAM, normalised by dividing by body weight (N) times height (m) and expressed as a 
percentage (Nm/(BWxHT)%), averaged over five trials. The normalised positive KAM 
angular impulse (positive area under KAM-time curve) (Nm.s/(BWxHt)%) was calculated as 
a secondary frontal plane knee moment variable.  We also calculated the normalised peak 
knee flexion moment during stance (KFM: Nm/(BWxHt)%) to ensure that this sagittal plane 
moment did not concurrently increase, and thus potentially counteract any beneficial effects 
of intervention on knee load (26).  
 
Self-reported pain and physical function 
The primary pain outcome was average overall knee pain during the past week. This, together 
with pain on walking during the past week, was assessed using a 100 mm visual analogue 
scale with terminal descriptors of “no pain” and “worst pain possible” (27). Such 
measurement has demonstrated reliability in OA (27). Pain was also assessed, along with 
stiffness and physical function, using the disease-specific valid and reliable Western Ontario 
McMaster Universities (WOMAC) Osteoarthritis Index (28). The physical function subscale, 
which comprises 17 questions, was used as a primary outcome measure.  
 
At the follow-up assessment, participants were asked to rate their a) overall change, b) 
change in pain and c) change in physical function (compared to baseline) on a seven-point 
ordinal scale (1 = much worse to 7 = much better).  All three ratings were dichotomised so 
that improvement was defined as a rating of ‘moderately better’ or ‘much better’.  
 
Muscle strength 
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Maximum, normalised, isometric strength (Nm/kg) was recorded for key muscle groups. 
Quadriceps and hamstring strength was measured in sitting at 60° knee flexion using an 
isokinetic dynamometer (KinCom 125-AP, Chattanooga Corp, TN, USA) with the best of 3 
maximal contractions used. Isometric hip abductor and hip internal and external rotation 
muscle strength were measured using a hand held dynamometer (Lafayette Manual Muscle 
Test System 01163, Lafayette, IN) (29). For the hip strength measurements, the mean of two 
maximal trials was used (29).  
 
Physical performance measures 
These included: timed stair climb assessing the time to walk up and down six 17.5 cm high 
steps as quickly as possible, using a hand rail if preferred (30); thirty second sit-to-stand test 
assessing the number of sit-stand-sits performed in 30 seconds (31); and balance tests 
including: timed single leg stance assessing the length of time single limb standing can be 
maintained up to 30 seconds with the best attempt from two trials recorded (32), step test 
whereby the participant stands on the study leg and the number of steps by the non-study leg 
onto a 15 cm high step and back to the floor in 15 seconds performed as quickly as possible is 
recorded (33),  and four-square step test which assesses the person’s ability to change 
directions while stepping (34).  
 
Health-related quality of life 
The Assessment of Quality of Life Instrument Version Two (AQoL II) was used to measure 
health-related quality of life. This questionnaire has strong psychometric properties and is 
more responsive than other widely-used scales (35).  
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Other measures 
Radiographic disease severity was rated using the Kellgren-Lawrence system (36). Baseline 
demographic information was collected. Co-interventions and adverse effects were 
determined from participant log books and physiotherapist treatment notes. Adherence was 
assessed by the number of physiotherapy sessions attended and by the number of home 
exercise sessions completed as recorded by participants in a log book. The percentage home 
exercise adherence was calculated by dividing the number completed by the maximum 
required number of 48.   
 
Physical activity was self-reported using the Physical Activity Scale for the Elderly (PASE) 
(37). This records both the level and type of recreational and occupational physical activity 
undertaken by participants during the previous week.  
 
Sample size 
Our primary endpoints were peak KAM during stance phase of walking, VAS overall knee 
pain, and WOMAC physical function score. The minimum clinically important difference 
(MCID) to be detected for a change in KAM is unknown. We powered the study to detect a 
between-group difference in change in KAM of 7.5% (an approximate decrease of 0.30 
Nm/(BW.HT)% in the NEXA group with no change in the QS group) as this may be 
associated with a significant decrease in risk of disease progression (7). The MCID for OA 
trials is a change in pain of 18 mm on VAS (38) and a change of six physical function 
WOMAC units (out of 68) (39). Based on our previous data, we assumed a between-
participant standard deviation of change in KAM of 0.40 Nm/(BW*HT)%, 30 mm for pain, 
and 12 units for WOMAC physical function, and a baseline to 13 week correlation in each 
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outcome measure of 0.60. Thus, the required sample for a two-tailed comparison of two 
groups using analysis of covariance with baseline values as covariates and assuming a 
baseline-to 13 week correlation of 0.60, when the standardised effect size is 0.5 (WOMAC 
physical function), power is 0.8 and type I error is .05 was 41 participants per group (40). 
This was increased to 50 per group to allow for a 15% dropout rate. Due to their larger 
standardised effect sizes, power for VAS and peak KAM endpoints was greater (92% and 
99%, respectively). 
 
Statistical analysis 
Main comparative analyses between groups were performed blinded to exercise type using an 
intention-to-treat approach with p-values of less than 0.05 considered statistically significant. 
To account for missing data, multiple imputation of missing follow-up measures were 
performed as a sensitivity analysis. Missing data were imputed for 12 participants in the 
NEXA group and 6 participants in the QS group using multiple imputation assuming data 
was missing at random (41). For continuous outcome measures, differences in mean change 
(follow-up minus baseline) was compared between groups using analysis of covariance 
adjusted for baseline values of the outcome. Walking speed was also included as a covariate 
for the KAM and peak KFM parameters in a subsequent analysis. Model diagnostic checks 
utilised residual plots. Results are presented as estimated differences with 95% confidence 
intervals. Likelihood of improvements overall, and in pain and function, were compared 
between groups using log binomial regression. Results are presented as relative risks with 
95% confidence intervals.  
 
Results 
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Of the 999 volunteers, 899 (90%) were ineligible or chose not to participate. In total, 100 
participants (50 NEXA, 50 QS) were randomised and 82 (38 (76%) NEXA, 44 (88%) QS) 
completed follow-up assessment (Figure 2). Baseline participant characteristics were similar 
between groups (Table 2). The cohort had mainly moderate to severe radiographic OA, was 
overweight and had moderate varus malalignment, on average 6o varus in males and 5o in 
females. More participants in the NEXA group withdrew due to increased pain or 
unanticipated decision to undergo total joint replacement (n=7) than in the QS group (n=1). 
Baseline characteristics of the 18 participants lost to follow-up were similar to those 
completing the study (data not shown).  
 
Outcome measures 
Table 3 demonstrates no differences between the NEXA and QS groups for changes in the 
peak KAM (0.148 (95% CI -0.039 to 0.335) Nm/BW.HT %, p=0.23), overall VAS pain (2.4 
(-6.0 to 10.8) mm, p=0.57) or WOMAC physical function (-0.8 (-4.0 to 2.4) units p=0.63). 
Observed between-group differences were smaller than the MCID and the 95% confidence 
intervals indicated that the ranges of plausible between-group differences were unlikely to 
have included differences of any practical importance. Results were unchanged when the 
sensitivity analysis was performed. Neither group showed a significant change in peak KAM 
from baseline whereas significant improvements in pain and physical function were achieved 
for both groups (Table 3).   
 
There were no between-group differences for changes in any of the secondary outcomes 
except for the timed single leg stance test, where the NEXA group improved and the QS 
group showed a decrement (p<0.001) (Table 3).  Results were unchanged when a sensitivity 
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analysis was performed. In the NEXA group, significant improvements were achieved in all 
secondary outcomes except for the KAM impulse, peak KFM and the PASE. In the QS 
group, significant improvements achieved in all outcomes except for KAM impulse, peak 
KFM, PASE, strength of the hip abductors, extensors and internal rotators, and timed single 
leg stance test.  
 
Likelihood of participant-perceived improvement overall, or for pain and physical function 
was not different between groups. Improvement overall and improvement in pain was 
reported by 27/46 (59%) participants in the NEXA group and 27/45 (60%) in the QS group 
(Relative risk (95% CI) 0.94 (0.67-1.33) p=0.74). Improvement in physical function was 
reported by 28/46 (61%) participants in the NEXA group and 29/45 (64%) in the QS group 
(0.91 (0.66-1.26) p=0.57). 
 
Adherence, adverse events, medication use and co-interventions 
The number of physiotherapy sessions attended ranged from 0-14 with a median (IQR) 
of 12 (3.8) for the NEXA group, and a range of 1-14 with a median (IQR) of 12 (4.5) for 
the QS group (p=0.98). The median (IQR) of the percentage of home exercise sessions 
completed was 82 (31)% by the NEXA group and 91 (26)% by the QS group (p=0.048). 
For those who completed the trial, adverse events were reported by 14/46 (28%) of the 
NEXA group and 10/44 (23%) of the QS group (p=0.483) and mostly related to 
increased knee pain (Table 5). Medication use and co-interventions during the trial were 
similar across groups (Table 4).  
 
Discussion  
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This study showed that neither 12 weeks of neuromuscular exercise nor quadriceps 
strengthening significantly influenced the external KAM during walking in individuals with 
mostly moderate to severe medial tibiofemoral OA and varus malalignment. However, both 
exercise programs provided similar improvements in clinical outcomes including pain, 
function and quality of life.  
 
The finding of no difference in change in KAM between exercise groups does not support our 
hypothesis. There are three main considerations in relation to this finding. The first is that 
neuromuscular exercise was unable to influence the biomechanical contributors to the KAM 
as intended, most likely the length of the ground reaction force lever arm at the knee. 
Shortening the lever arm to reduce the KAM can be achieved through biomechanical 
alterations proximal or distal to the knee to bring the ground reaction force vector closer to 
the knee, and/or the knee closer to this vector (42). While neuromuscular exercises were 
performed in weight bearing and focused on lower limb and knee position control, they did 
not specifically target changes in KAM during walking. Instead, it may be that gait retraining 
interventions are needed. For example, there is evidence that teaching people to lean the 
trunk towards the affected limb, alter the foot progression angle or adopt a medial thrust type 
gait can reduce the KAM during walking (42, 43). It is also possible that training both limbs 
in a neuromuscular exercise program is necessary to facilitate stabilisation at the pelvis and 
hip, utilize the cross-over effect of motor learning, and maintain ideal lower limb alignment. 
We chose to exercise only the affected limb to reduce participant-burden. However, this may 
have attenuated any potential KAM-reducing benefits.  
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The second issue relates to our choice of task to measure KAM. We selected walking because 
of the established link between KAM during walking and OA structural disease progression 
(7, 8). It is possible that reductions in KAM following exercise training might have been 
observed if a more demanding task was used. An uncontrolled pilot study (14) involving 13 
middle-aged people with early knee OA evaluated a comparable neuromuscular exercise and 
found a 14% reduction in peak KAM during a difficult one-legged rise task but not during 
walking. However, the clinical implications of a reduction in KAM during a one-legged rise 
task in terms of disease progression are not clear.  
 
The third issue relates to the impact of the attributes of our medial knee OA sample. Our 
participants had a mean static varus of approximately 5 degrees representing moderate 
malalignment with 10% having severe malalignment (>10 degrees). It could be suggested 
that reducing the KAM with exercise (or other interventions) in the face of a seemingly fixed 
varus deformity and more severe disease may not be possible.  However, while static varus 
malalignment is an important driver of the KAM (44), alignment is also a dynamic 
characteristic that can change during gait (45) and independently influence the KAM (46). 
Thus, there is at least potential for neuromuscular changes from exercise to influence this 
dynamic alignment and therefore the KAM, particularly where that exercise targets a more 
neutral dynamic alignment and muscular control of proximal and distal segments. In light of 
this, the subgroup of people with medial knee OA and varus malalignment are relevant to 
investigate the effects of neuromuscular exercise given their generally higher KAM (44). 
However, as we found no effect, it is possible that any benefits of neuromuscular exercise 
may be more evident in those at risk of knee OA (such as following joint injury) or with early 
OA as has been found in uncontrolled pilot studies (14, 18).  
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We also showed no significant effect of quadriceps strengthening exercise on the KAM 
despite significant strength gains of 10%. This is not necessarily surprising as single plane, 
non-weight bearing exercises are not specifically targeted at altering the magnitude or 
orientation of the ground reaction force or position of the knee – the primary determinants of 
the KAM during walking. This concurs with our prior RCT in people with medial knee OA 
with or without varus malalignment using the same exercise program (11). Other clinical 
trials have found no change in the KAM following a hip strengthening program in people 
with medial knee OA (48, 49) or following a high intensity lower limb strengthening exercise 
in people with knee OA involving any compartment (12, 50). Taken together, there is 
currently little evidence to support a KAM-modifying effect of exercise in people with 
medial or generalised moderate to severe knee OA.  
 
Although there was no influence of exercise on the KAM, an indicator of medio-lateral knee 
load distribution, we cannot exclude an effect of exercise on the magnitude of compressive 
knee load. While good correlations have been found between the KAM and compressive joint 
load as calculated by complex musculoskeletal modeling (51), single patient studies using 
instrumented knee replacements have shown that under some circumstances the two may not 
always correspond. This lack of concordance may be due to concomitant alterations in other 
knee joint moments, particularly the KFM (26), and to alterations in muscle activation 
patterns (52); (53) that are not accounted for in estimation of KAM using inverse dynamics. 
While the KFM was not different between groups and did not change, it is possible that 
muscle activation may have been affected by exercise and hence altered knee load.     
 
 18 
While the KAM itself is a predictor of disease progression (7, 8), we cannot determine the 
direct effects of neuromuscular exercise on structural outcomes.  A more intensive 16-week 
supervised neuromuscular exercise program performed for one hour thrice weekly 
demonstrated improved cartilage quality assessed using delayed gadolinium-enhanced 
magnetic resonance imaging in middle-aged people (54). However, the only RCT to assess 
the effects of exercise on structural disease progression as the primary outcome in patients 
with established knee OA found a non-significant tendency toward less frequent progression 
of joint space narrowing over 30 months (55). Further longer-term studies are needed before 
definitive conclusions can be made as to whether exercise can modify structural disease 
progression in subgroups at risk of, or with established OA. 
 
Contrary to our hypothesis, both exercise groups showed similar improvements in pain 
(NEXA 37%, Effect Size 1.04; QS 41%, ES 1.20) and physical function (NEXA 29%, ES 
0.80; QS 26%, ES 0.74) with large effect sizes. The between group differences were small 
with confidence intervals that fell well short of the minimal clinically important differences 
(38, 39). The benefits of exercise for clinical outcomes in knee OA are supported by meta-
analyses (9) and although there are few direct comparisons of different types of exercise, the 
results of pooled analyses suggest similar improvements for all types (9). Our findings concur 
with this conclusion. Overall, our data indicate that practitioners should prescribe the type of 
exercise that most suits the patient’s needs and/or preferences based on individual 
assessment.   
 
Our findings of improvements in pain and function with quadriceps strengthening in people 
with medial knee OA and varus malalignment do not completely agree with those of our 
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previous clinical trial using the same strength exercise program (11). A potential explanation 
may be the greater number of therapist sessions in the current study (14 versus 7). This is 
supported by a Cochrane review showing significantly greater benefits for pain and function 
with exercise programs involving more than 12 contacts with a health professional compared 
with those involving 12 or less contacts (9).   
 
The strengths of our study include the RCT design with attention to key methodological 
features. Limitations include an inability to blind participants to treatment allocation, 
although the research hypotheses were not disclosed. We did not include a control group not 
receiving treatment, and as such, the symptomatic benefits may be related to the therapeutic 
environment and/or expectation of benefit rather than exercise per se (56). Another limitation 
is the greater number of drop-outs in the NEXA group due to pain and joint replacement 
surgery. However the results were unaltered when sensitivity analyses were performed. 
Nevertheless, the weight bearing nature of neuromuscular exercises may be more symptom-
provocative compared to non-weight bearing quadriceps strengthening. This might also partly 
explain the lower home exercise adherence rates in the NEXA group. Finally, as our sample 
comprised patients with mostly moderate to severe knee OA with moderate varus 
malalignment, our results cannot necessarily be generalised to those with milder disease or 
differing amounts of malalignment. While different effects may be seen in early stage 
disease, we restricted our sample to those with definitive OA to achieve a more homogenous 
sample. 
 
In conclusion, our results showed similar improvements in pain and function following 
neuromuscular or quadriceps strengthening exercise in a cohort with moderate varus 
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malalignment and mostly moderate to severe medial knee OA. They do not support the 
premise that such forms of exercise can influence the KAM, a key predictor of structural 
disease progression. 
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Figure 1: Diagram showing two examples of exercises from the neuromuscular 
program. In these exercises, note that the participant is required to maintain their knee 
in an aligned neutral position as they slide the leg forwards/backwards or sideways.  An 
elastic resistance band applies a varus directed force that requires the participant to 
counteract this by pulling in a valgus direction in order to maintain the knee position.   
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Figure 2. Flow diagram of study protocol 
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Table 1. Summary of exercise programs (see Appendix for further details) 
Neuromuscular exercise  Quality of movement emphasised with aim to 
position knee over foot, and to avoid a medial or 
lateral position of the knee in relation to the foot. 
Effort rating of 5-8 out of 10† 
1. Forwards and backwards sliding or 
stepping 
Standing on affected leg and sliding or stepping 
opposite leg forward and backwards. This was 
progressed by adding elastic resistance band 
around the affected leg to apply a varus directed 
force during the movement which the patient had 
to counteract in order to maintain the knee in the 
neutral aligned position.  
3 sets of 10 repetitions 
2. Sideways exercises Standing on affected leg and sliding or stepping 
opposite leg sideways progressing to adding 
elastic resistance band around the study leg to 
apply a varus directed force throughout 
movement (which the patient had to counteract in 
order to maintain the knee in the neutral aligned 
position), standing on foam and closing eyes 
during the movement. 
3 sets of 10 repetitions 
3. Functional hip muscle strengthening Standing isometric abduction (2 sets of 5 
repetitions) with progression through to elastic 
band resisted abduction during side stepping (2 x 
30 steps) 
4. Functional knee muscle 
strengthening 
Squatting against a wall progressing through to 
rising from sitting with increased weight taken 
through the study leg 
3 sets of 10 repetitions 
5. Step-ups and down Stepping on to a step with progression to add 2kg 
hand weights and then step down with forward 
touch down of opposite leg. 
3 sets of 10 repetitions 
6. Balance Standing on affected leg. Progressions include 
adding arm movements and then stepping 
forward on to foam. 
2 minutes practice 
Quadriceps strengthening exercise  Each exercise 2-3 sets of 10 repetitions with 5-10 
second hold 
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Resistance equivalent to 10-repetition maximum 
and rating of 5-8 out of 10† 
1. Quads over a roll (inner range knee 
extension) 
Using resistance of ankle weights 
2. Knee extension in sitting Sitting with knee at 90° flexion, fully extend 
knee using resistance of ankle weights 
 
3. Knee extension with hold at 30° 
knee flexion 
Sitting with knee at 90° flexion, extend to 30° 
using resistance of ankle weights 
4. Straight leg raise  Supine, raise leg to 30° hip flexion using 
resistance of ankle weights 
 
5. Outer range knee extension Sitting with knee at 90° flexion, extend to 60° 
against resistance of elastic band 
† using modified Borg rating of perceived exertion scale (24) 
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Table 2: Demographic and clinical characteristics of the NEXA and QS groups given as 
the mean (standard deviation) or number (%) unless otherwise stated 
 
Characteristic 
NEXA 
n=50 
QS 
n=50 
Age (years) 62.7 (7.3) 62.2 (7.4) 
Symptom duration (months - median and 
interquartile range)  
60.0 (96.0) 84.0 (93.6) 
Height (cm) 168.1 (9.2) 165.6 (10.1) 
Body mass (kg) 83.8 (13.5) 81.6 (15.1) 
Body mass index  (kg/m2) 29.6 (3.9) 29.7 (4.3) 
Male (n-%) 24 (48%) 24 (48%) 
Affected Knee (Right:Left) 30:20 23:27 
Unilateral symptoms (n-%) 20 (40%) 19 (38%) 
Dominant side affected  (n-%) 28 (56%) 25 (50%) 
Knee alignment (o) ¥ 177.3 (3.0) 176.4 (3.9) 
    Males 178.1 (2.7) 175.2 (4.5) 
    Females 176.5 (3.1) 177.1 (3.3) 
Radiographic disease severity (n-%)†   
   Grade 2 9 (18%) 13 (26%) 
   Grade 3 21 (42%) 22 (44%) 
   Grade 4  20 (40%) 15 (30%) 
Current drug use (n-%)††   
   Analgesia (paracetamol combinations) 17 (34%) 20 (40%) 
   Non-steroidal anti-inflammatories 10 (20%) 10 (20%) 
   COX-2 inhibitors 3 (6%) 4 (8%) 
   Opioids 1 (2%) 1 (2%) 
   Topical anti-inflammatories 3 (6%) 5 (10%) 
   Glucosamine/chondroitin products 24 (48%) 23 (46%) 
   Topical liniment rubs 9 (18%) 10 (20%) 
   Fish oil 3 (6%) 8 (16%) 
† using the Kellgren and Lawrence grading system 
†† defined as at least once per week 
¥ anatomical alignment where neutral alignment is 181o for females and 183o for males and varus is <181o for 
females and < 183o for males. 
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Table 3. Mean (SD) of groups, mean (SD) difference within groups, and mean (95% CI) difference between groups adjusted for baseline 
scores 
Outcome Groups Difference within groups Difference between 
groups * 
 Week 0 Week 13 Week 13 minus Week 0 NEXA minus QS 
 NEXA 
(n=50) 
QS 
(n=50) 
NEXA 
(n=38) 
QS 
(n=44) 
NEXA 
(n=38) 
QS 
(n=44) 
Mean [CI] 
 
P 
Peak KAM (Nm/(BW.BH)%) 3.05 (0.90) 3.21 (0.88) 3.26 (0.95) 3.30 (0.79) 0.12 [-0.04, 0.29] -0.04 [-0.18, 0.10] 0.13 [-0.08, 0.33] 0.23 
Overall VAS pain (mm) 54.0 (13.3) 54.2 (16.8) 34.1 (23.6) 31.4 (19.3) -19.9 [-26.9, -12.9] -22.0 [-27.9, -16.1] 2.4 [-6.0, 10.8] 0.57 
WOMAC Physical Function (0-68) 26.0 (9.1) 28.2 (9.9) 18.3 (9.6) 20.1 (9.8) -7.5 [-10.1, -4.9] -7.3 [-9.7, -4.9] -0.8 [-4.0, 2.4] 0.63 
KAM Impulse (Nm.sec/(BW.BH)%) 1.15 (0.37) 1.21 (0.36) 1.20 (0.36) 1.23 (0.37) 0.02 [-0.05, 0.09] -0.02 [-0.08, 0.03] 0.03 [-0.05, 0.12] 0.47 
Peak KFM (Nm/(BW.BH)%) 4.02 (1.38) 3.96 (1.59) 3.89 (1.64) 4.05 (1.79) -0.03 [-0.39, 0.32] 0.07 [-0.18, 0.32] -0.11 [-0.54, 0.31] 0.60 
Walking velocity (m/sec) 1.21 (0.18) 1.19 (0.22) 1.25 (0.20) 1.24 (0.21) 0.04 [0.00, 0.09] 0.03 [0.00, 0.07] 0.01 [-0.04, 0.07] 0.67 
Walking VAS pain (mm) 59.5 (15.0) 55.3 (22.4) 39.6 (25.9) 40.0 (22.9) -19.6 [-27.5, -11.8] -15.8 [-22.7, -8.9] -2.0 [-11.3, 7.4] 0.67 
WOMAC Pain (0-20) 8.1 (2.2) 8.8 (3.3) 6.4 (3.1) 6.4 (2.9) -1.7 [-2.6, -0.9] -2.4 [-3.1, -1.7] 0.4 [-0.6, 1.4] 0.43 
WOMAC Stiffness (0-8) 4.3 (1.6) 4.4 (1.6) 3.6 (1.4) 3.9 (1.8) -0.7 [-1.1, -0.2] -0.5 [-1.0, 0.0] -0.2 [-0.8, 0.3] 0.41 
AQoL2 (-0.04 -1.00) 0.73 (0.14) 0.73 (0.18) 0.78 (0.14) 0.78 (0.16) 0.04 [0.00, 0.09] 0.03 [0.00, 0.06] 0.01 [-0.03, 0.05] 0.67 
PASE (0->400) 159.9 (82.7) 171.7 (89.8) 175.8 (112.0) 196.2 (88.4) 15.0 [-13.4, 43.5] 19.2 [-2.8, 41.2] -9.1 [-42.9, 24.6] 0.59 
Quadriceps Strength (Nm/kg) 1.44 (0.42) 1.47 (0.47) 1.59 (0.47) 1.62 (0.51) 0.15 [0.08, 0.21] 0.09 [0.02, 0.16] 0.06 [-0.04, 0.16] 0.22 
Hamstring Strength (Nm/kg) 0.66 (0.20) 0.71 (0.23) 0.71 (0.23) 0.79 (0.26) 0.04 [0.00, 0.08] 0.05 [0.01, 0.09] -0.02 [-0.07, 0.04] 0.57 
Hip Abduction Strength (Nm/kg) 1.09 (0.38) 1.19 (0.44) 1.20 (0.45) 1.23 (0.41) 0.11 [0.02, 0.20] -0.01 [-0.08, 0.06] 0.09 [-0.02, 0.21] 0.11 
Hip Extension Strength (Nm/kg) 1.63 (0.56) 1.78 (0.75) 1.75 (0.54) 1.86 (0.70) 0.14 [0.02, 0.26] -0.03 [-0.14, 0.08] 0.11 [-0.04, 0.26] 0.15 
Hip Int Rotation Strength (Nm/kg) 0.47 (0.17) 0.52 (0.18) 0.50 (0.17) 0.56 (0.17) 0.05 [0.03, 0.08] 0.03 [-0.01, 0.06] 0.01 [-0.03, 0.05] 0.60 
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Hip Ext Rotation Strength (Nm/kg) 0.38 (0.14) 0.39 (0.14) 0.41 (0.12) 0.45 (0.14) 0.03 [0.01, 0.06] 0.04 [0.01, 0.07] -0.02 [-0.05, 0.02] 0.42 
Timed Stair Climb (s) 7.89 (2.45) 8.08 (3.89) 7.11 (2.23) 6.84 (1.88) -0.67 [-1.17, -0.18] -0.69 [-1.21, -0.16] 0.11 [-0.46, 0.68] 0.69 
30 Second Sit to Stand (reps) 10.7 (2.3) 10.6 (2.9) 11.7 (2.1) 12.0 (2.5) 1.0 [0.4, 1.6] 0.9 [0.4, 1.4] -0.03 [-0.72, 0.66] 0.93 
Four Square Step Test (s) 9.1 (2.1) 8.6 (2.3) 8.1 (1.8) 7.9 (1.7) -0.8 [-1.2, -0.5] -0.3 [-0.6, 0.0] -0.38 [-0.79, 0.03] 0.07 
Step Test (reps) 12.5 (3.1) 13.1 (3.6) 14.1 (3.2) 14.4 (4.3) 1.5 [0.8, 2.1] 0.9 [0.2, 1.6] 0.46 [-0.45, 1.37] 0.32 
One Leg Balance Test (s) ¥        15.2 (11.9) 20.1 (11.5)  20.7 (9.9) 18.9 (11.2) 5.0 [2.7, 7.3] -1.8 [-3.7, 0.1] 5.58 [3.04, 8.11] <0.001 
¥ Number completed 30 secs: NEXA 0 weeks n=15 (30%) and 13 weeks n=16 (42%); QS 0 weeks n=23 (46%) and 13 weeks n=17 (39%) 
* controlling for baseline values of the variable 
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Table 4: Adverse events, medication use and co-interventions according to group  
Measures NEXA QS 
Adverse events †  13/46 (28%) 10/44 (23%) 
     Increased knee pain  10 (22%) 8 (18%) 
     Back pain 1 (2%) 1 (2%) 
     Pain in other area 2 (4%) 1 (2%) 
     Hip pain 2 (4%) 1 (2%) 
     Swelling/inflammation 3 (7%) 1 (2%) 
     Stiffness 1 (2%) 0 (0%) 
Medication use ¥   
   Analgesia (paracetamol combinations) 15 (32%) 10 (23%) 
   Non-steroidal anti-inflammatories 10 (21%) 6 (14%) 
   COX-2 inhibitors 1 (2%) 3 (7%) 
   Opioids 2 (4%) 0 (0%) 
   Topical anti-inflammatories 5 (11%) 1 (2%) 
   Glucosamine/chondroitin products 26 (55%) 23 (52%) 
   Topical liniment rubs 5 (11%) 5 (11%) 
   Fish oil 1 (2%) 4 (9%) 
Co-interventions  4/47 (9%) 2/44 (5%) 
     Other physiotherapy 2 (4%) 1 (2%) 
     Exercise 3 (6%) 0 (0%) 
     Osteopathy 0 (0%) 1 (2%) 
     Hydrotherapy 1 (2%) 0 (0%) 
     Elastic bandage 1 (2%) 0 (0%) 
† defined as any problem from the treatment that lasted for more than two days and/or caused 
participant to seek other treatment 
¥ n=47 in NEXA group and n=44 in QS group completed this information 
 
 
 
